OS Therapies Incorporated Share Price & Technical Analysis
OSTX · $1.70 (-0.58%)
Healthcare / Biotechnology
$1.70
-0.58%
OS Therapies Incorporated, a clinical stage biopharmaceutical company, focuses on the identification, development, and commercialization of treatments for osteosarcoma and other solid tumors in the United States. The company's pipeline includes OST-HER2, an off-the-shelf immunotherapy for osteosarcoma patients; and OST-tunable drug conjugate (OST-tADC), an antibody-drug conjugate (ADC) silicone di…
Price chart
Seasonality
Jun has 1 positive and 1 negative years (last 3 years shown)
-19% return in Jun, 27% avg return in past 3 year Jun month.
26% return in 2026, -13% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | 0% | 7% | -7% | 21% | 24% | -19% | – | – | – | – | – | – | 26% |
| 25 | -58% | -11% | -12% | 33% | -29% | 27% | -5% | 33% | -13% | 0% | -5% | -22% | -62% |
| 24 | – | – | – | – | – | – | – | 3% | -32% | -7% | -22% | 95% | 37% |
Monthly return % by calendar month · historical pattern, not a forecast
Bearish · Downtrend · Neutral
OS Therapies Incorporated, a clinical stage biopharmaceutical company, focuses on the identification, development, and commercialization of treatments for osteosarcoma and other solid tumors in the United States. The company's pipeline includes OST-HER2, an off-the-shelf immunotherapy for osteosarcoma patients; and OST-tunable drug conjugate (OST-tADC), an antibody-drug conjugate (ADC) silicone dioxide linker technology, with a plug-and-play platform that features tunable pH sensitive silicone linkers. The company was incorporated in 2018 and is based in Grasonville, Maryland.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$76.83M
P/E ratio
—
52W high
$2.57
52W low
$1.15
Volume
2,75,320
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹35,920
Abbott Laboratories Cede…
₹33,540
Eli Lilly And Company Ce…
₹30,700
Unitedhealth Group Inc C…
₹18,590
₹7,059
Frequently asked questions
- What is OS Therapies Incorporated share price today?
- OS Therapies Incorporated (OSTX) last traded around $1.70 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does OSTX have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for OSTX. Download the app for real-time alerts.
- How can I analyze OS Therapies Incorporated stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.